Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q3 2022 · 10-Q
Revenue$109.19M$109.19M+77.0% vs Q3 2021 Net Income-$16.85M-$16.85MN/M vs Q3 2021 EPS Diluted-$0.60-$0.60N/M vs Q3 2021 Gross Profit$89,402,000+68.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flowderived$11,002,000N/M Free Cash Flowderived$7,490,000N/M Margins · derivedGross margin81.9%−4.1 pt vs Q3 2021
Operating margin-15.7%+0.1 pt vs Q3 2021
Net margin-15.4%+1.3 pt vs Q3 2021
ended Sep 30, 2022 · filed Nov 1, 2022 · 32 d after period end